Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Neoplasm Metastasis 2Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Thrombocytosis 1Somatostatinoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Radiotherapy 11Fluorouracil 8Cisplatin 6Oxaliplatin 5Carboplatin 5Paclitaxel 4Neoadjuvant Therapy 4Leucovorin 4Gefitinib 4pembrolizumab 3Radiation 3Irinotecan 3Taxes 2Surgical Procedures, Operative 2Gemcitabine 2Docetaxel 2Cetuximab 2130-nm albumin-bound paclitaxel 2vandetanib 1spartalizumab 1sargramostim 1romidepsin 1ribociclib 1regorafenib 1oblimersen 1incomplete Freund's adjuvant 1fish oil triglycerides 1dehydroftorafur 1ceritinib 1benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Adenocarcinoma Of Esophagus × dehydroftorafur × Clear all
NCT01307956 2023-10-26

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

University of Nebraska

Phase 2 Terminated
11 enrolled 11 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡